TOP - August 2015, Vol 8, No 3 - From the Editors
Patrick J. Medina, PharmD, BCOP
Professor of Clinical and Administrative Sciences
University of Oklahoma College of Pharmacy
Tulsa, OK
Steve Stricker, PharmD, MS, BCOP
Takeda Oncology
Florence, KY

In this month’s issue of The Oncology Pharmacist, we present coverage of the 2015 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on Supportive Care in Cancer. We highlight presentations on the effectiveness of rolapitant for chemotherapy-induced nausea and vomiting, as well as data on the association between osteonecrosis of the jaw and medication.

In this issue’s reader poll, we ask whether you counsel patients with cancer on smoking cessation. Please visit our website, www.TheOncologyPharmacist.com, and let us know if this is a conversation you have with your patients. You can also send comments to info@TheOncologyPharmacist.com. “Virtually no institutions reported systematic and consistent mechanisms for fostering cessation,” Peter G. Shields, MD, citing the American Association for Cancer Research Task Force on Tobacco.

We are also featuring an interview with Michael Koraleski, PharmD, Patient Care Pharmacist, Nebraska Methodist Hospital, Omaha, who discussed with us his presentation at the 11th annual Hematology/Oncology Pharmacy Association conference on the newest US Pharmacopeial (USP) Convention Chapter 800 Standards (see “Meeting USP Chapter 800 Head On,”).

We hope you will enjoy this issue, and look forward to your feedback.

Last modified: August 6, 2015